Advertisement Alpha Innotech names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Alpha Innotech names new CFO

Alpha Innotech, a provider of bioanalytical systems for drug discovery and life science research, has appointed Michael Henighan as its new CFO and principal accounting officer.

Prior to joining the company as corporate controller in May 2008, Mr Henighan was vice president and corporate controller at HemoSense and corporate controller at Cholestech.

Ron Bissinger, CEO of Alpha Innotech, said: “In the few short months Michael has been with us he’s already been a great asset as we continue building profitable growth momentum. We’re delighted to appoint Michael as our top financial executive.”